Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope

Pivotal Phase 3 Theranostic Trials: Future Indications.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer.

European urology focus·2026

Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Diagnostic performance of CT/MRI LI-RADS radiation treatment response algorithm v2024 for Y-90 radioembolization.

European journal of radiology·2026

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026

From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted [68Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [18F]FDG PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Beta Atlas: Charting Global Production of Nonconventional β--Emitters for Targeted Radiopharmaceutical Therapy-Part 1.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Are Urooncologists Onboard?

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Radiopharmaceutical Therapy-Linked Tumor Resistance: Immune Evasion, Nonimmune Mechanisms, and Immunometabolic Vulnerabilities.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Caregivers in amyotrophic lateral sclerosis (ALS): preliminary results between paid care and family care.

Health psychology and behavioral medicine·2026

Provider Trust in a Sample of Transgender Latinas in the US South.

Health behavior and policy review·2026

Pseudo-professional mechanism of collaborative mental health support in low-resource county-level contexts in China.

Frontiers in psychiatry·2026

Family Ties online help: Pilot evaluation of an online intervention to reduce the impact of parental conflict on children.

Psychology and psychotherapy·2026

Network Characteristics of Social Support Sources for People Living with HIV Under Community Follow-Up: A Social Network Analysis in Luzhou, China.

AIDS and behavior·2026

Prosthodontic Services in Cleft Care: Institutional Barriers and Pathways to Equity.

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association·2026

Related Experiment Videos

Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope

Related Concept Videos

Pivotal Phase 3 Theranostic Trials: Future Indications.

PSMA-PET Tumor Volume Stratifies Nonmetastatic Castration-resistant Prostate Cancer.

Clinical Trial Protocol for LPS-Boost: Intensified [177Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.

Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

Diagnostic performance of CT/MRI LI-RADS radiation treatment response algorithm v2024 for Y-90 radioembolization.

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

From Metabolism to Molecular Phenotype: Carbonic Anhydrase IX-Targeted [68Ga]Ga-DPI-4452 PET/CT in Renal Cell Carcinoma: A Prospective Multicenter Comparison with [18F]FDG PET/CT.

From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms.

Beta Atlas: Charting Global Production of Nonconventional β--Emitters for Targeted Radiopharmaceutical Therapy-Part 1.

Are Urooncologists Onboard?

Radiopharmaceutical Therapy-Linked Tumor Resistance: Immune Evasion, Nonimmune Mechanisms, and Immunometabolic Vulnerabilities.

Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.

Caregivers in amyotrophic lateral sclerosis (ALS): preliminary results between paid care and family care.

Provider Trust in a Sample of Transgender Latinas in the US South.

Pseudo-professional mechanism of collaborative mental health support in low-resource county-level contexts in China.

Family Ties online help: Pilot evaluation of an online intervention to reduce the impact of parental conflict on children.

Network Characteristics of Social Support Sources for People Living with HIV Under Community Follow-Up: A Social Network Analysis in Luzhou, China.

Prosthodontic Services in Cleft Care: Institutional Barriers and Pathways to Equity.

Related Experiment Videos

Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope

Related Concept Videos

Related Articles